N-acetyl-L-leucine accelerates vestibular compensation after unilateral labyrinthectomy by action in the cerebellum and thalamusTargeting epileptogenesis-associated induction of neurogenesis by enzymatic depolysialylation of NCAM counteracts spatial learning dysfunction but fails to impact epilepsy developmentInternational veterinary epilepsy task force consensus proposal: diagnostic approach to epilepsy in dogsCellular localization of Y-box binding protein 1 in brain tissue of rats, macaques, and humans.Naturally occurring Clostridium perfringens nontoxic alpha-toxin variant as a potential vaccine candidate against alpha-toxin-associated diseases.Drug resistance in brain diseases and the role of drug efflux transporters.Celecoxib treatment restores pharmacosensitivity in a rat model of pharmacoresistant epilepsy.Animal and human data: where are our concepts for drug-resistant epilepsy going?LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsyInternational veterinary epilepsy task force consensus report on epilepsy definition, classification and terminology in companion animals.International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in EuropeInternational Veterinary Epilepsy Task Force recommendations for a veterinary epilepsy-specific MRI protocolInternational veterinary epilepsy task force recommendations for systematic sampling and processing of brains from epileptic dogs and cats.Finding a better drug for epilepsy: antiepileptogenesis targets.Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach.Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies?Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches.The role of p-glycoprotein in psychiatric disorders: a reliable guard of the brain?Role of CNS efflux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport.Pharmacoresistance.Canine epilepsy as a translational model?CNS transporters and drug delivery in epilepsy.Polymorphic variants of the multidrug resistance gene Mdr1a and response to antiepileptic drug treatment in the kindling model of epilepsy.Impact of the neural cell adhesion molecule-derived peptide FGL on seizure progression and cellular alterations in the mouse kindling model.Minocycline fails to exert antiepileptogenic effects in a rat status epilepticus model.(R)-[11C]PK11195 brain uptake as a biomarker of inflammation and antiepileptic drug resistance: evaluation in a rat epilepsy model.Pre-treatment with the NMDA receptor glycine-binding site antagonist L-701,324 improves pharmacosensitivity in a mouse kindling model.Effect of eslicarbazepine acetate in the corneal kindling progression and the amygdala kindling model of temporal lobe epilepsy.Lacosamide treatment following status epilepticus attenuates neuronal cell loss and alterations in hippocampal neurogenesis in a rat electrical status epilepticus model.Impact of the NCAM derived mimetic peptide plannexin on the acute cellular consequences of a status epilepticus.Targeting the endocannabinoid system in the amygdala kindling model of temporal lobe epilepsy in mice.Age-dependent decline of blood-brain barrier P-glycoprotein expression in the canine brain.Pyrrolidine dithiocarbamate protects the piriform cortex in the pilocarpine status epilepticus model.Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulation.Synergism of perampanel and zonisamide in the rat amygdala kindling model of temporal lobe epilepsy.A retrospective evaluation of species-specific sensitivity for neurological signs in toxicological studies: Is the dog more sensitive than the non-human primate?Proteomic profiling of epileptogenesis in a rat model: Focus on inflammation.Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR- rats.
P50
Q28544952-98383577-7C02-41C3-AA6A-7411EBF79AF8Q28567781-8DECB2A3-93EF-491B-A658-6E048A9B9ED2Q30662836-2BEB8363-480B-4E9E-9FB7-2D93E1A5E9FFQ33422583-4C369892-CF98-4D6D-8D82-E69CEF339E3CQ33554674-75A4E643-745C-4831-B01A-EBA493373796Q33988704-38C09FFA-5FDF-4059-BCFD-457160878C75Q34112939-1C09B685-F996-4165-9795-6F84B03D710AQ34707408-3E5B6998-B808-4D32-86FD-3EC606492038Q35028128-B9872DC2-F1DD-41CD-B2FF-B7100D029762Q35757818-85AAC1C8-B0D1-433B-924F-41EE658E7173Q35758281-03882404-913C-4E7C-B3E0-B0F89859E1D7Q35758344-73050D27-75C1-4BAF-AF2B-C06139D7EC04Q35759518-02931710-82B2-40B0-894E-F98C9F646795Q35760730-7B3C0528-783E-43AF-BC17-B4292A7DB9F4Q37232240-A0ADA51D-614F-4D2A-B9EC-D6C9950A581CQ37629066-477E9EF0-B9AD-423D-94DB-10905E7C87DEQ37755398-4473A4B3-615F-481E-B350-03F28DA29561Q37806763-8DD0D6B6-96B8-44A2-8782-42C9706DD56AQ37932591-0173B50F-4C8B-4535-967B-842B96BD7445Q37972517-17D9913E-198B-43AE-B75D-ED88594323D6Q38039641-648E334B-2313-48FE-869C-9602C6BD97DCQ38090658-ADF24868-84B4-4004-BA80-A6DD8419DAA8Q38116081-87130112-3A7B-4B1B-9229-CC7D7A92F619Q38308501-3D75EBD6-736C-4E58-9E17-89744EA165C7Q38419833-D04D6390-F0A2-496D-BD34-959142904B52Q38930679-05016740-CEDE-418C-8EF6-2F8C5D666E5DQ39183565-3F250ADE-1569-4583-A95B-CDD48C780CEDQ39225337-DB88DCB8-E601-45C3-904E-D8B5FB2E5B64Q39293194-A27FB164-FF9E-49CD-84DF-6629AB6B7641Q39430562-14600F5C-B4C1-405A-B533-1463D65F8AF6Q39725016-ADE700AA-1343-4B3F-B9E8-C98E6960C1C8Q39744283-238E182C-EC8A-4B8B-B8A8-15C3254737A7Q39937935-7291232D-1FEA-413D-93BA-840862715389Q39945676-48F1F04B-0724-47ED-AFA2-FDFB78B1928EQ39973896-5CFDE81B-36D8-42E5-9898-897F9B5BA704Q40016074-311385C5-441C-42A8-A151-777B0F5FAF9FQ40143961-AD1C9839-69D5-4F84-B25E-775CF87112E6Q40190915-1E6E8A76-BF09-48B6-98BB-C95FBCF2032EQ40219587-EDB9304A-67E1-44EC-BEB7-1F8C1FF485C2Q40547405-70837A72-594B-46D7-AD22-D1B66CF609E3
P50
description
deutsche Pharmakologin und Hochschullehrerin
@de
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Heidrun Potschka
@ast
Heidrun Potschka
@de
Heidrun Potschka
@en
Heidrun Potschka
@es
Heidrun Potschka
@nl
Heidrun Potschka
@sl
type
label
Heidrun Potschka
@ast
Heidrun Potschka
@de
Heidrun Potschka
@en
Heidrun Potschka
@es
Heidrun Potschka
@nl
Heidrun Potschka
@sl
prefLabel
Heidrun Potschka
@ast
Heidrun Potschka
@de
Heidrun Potschka
@en
Heidrun Potschka
@es
Heidrun Potschka
@nl
Heidrun Potschka
@sl
P214
P227
P106
P21
P214
P227
1052446922
P31
P496
0000-0003-1506-0252
P569
1968-05-14T00:00:00Z